Bio-Rad receives pre-market approval for HIV test from FDA
Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.
bio rad
Copyright © 2024 | WordPress Theme by MH Themes